ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

SNDX Syndax Pharmaceuticals Inc

20.57
-0.22 (-1.06%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Syndax Pharmaceuticals Inc SNDX NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.22 -1.06% 20.57 10:00:00
Open Price Low Price High Price Close Price Previous Close
20.43 20.13 20.80 20.57 20.79
more quote information »

Recent News

Date Time Source Heading
11/4/202406:05PRNUSSyndax Announces Participation at the Stifel 2024 Virtual..
08/4/202421:00PRNUSSyndax Presents Positive Pediatric Data from Pivotal..
06/4/202407:05PRNUSSyndax Pharmaceuticals Reports Inducement Grants Under..
28/3/202422:00PRNUSSyndax Announces Completion of Enrollment in AUGMENT-101..
27/3/202407:05PRNUSSyndax Announces FDA Priority Review of NDA for Revumenib..
18/3/202422:00PRNUSSyndax Announces Appointment of Steven Closter as Chief..
02/3/202408:05PRNUSSyndax Pharmaceuticals Reports Inducement Grants Under..
28/2/202409:28EDGAR2Form S-3ASR - Automatic shelf registration statement of..
28/2/202409:21EDGAR2Form S-8 - Securities to be offered to employees in employee..
28/2/202408:05PRNUSSyndax Pharmaceuticals Reports Fourth Quarter and Full Year..
28/2/202408:03EDGAR2Form 8-K - Current report
26/2/202423:00PRNUSSyndax Announces Participation at Two Upcoming Investor..
21/2/202408:05PRNUSSyndax to Announce Fourth Quarter and Year-end 2023..
15/2/202404:50EDGAR2Form SC 13G - Statement of acquisition of beneficial..
14/2/202423:01EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202413:44EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
10/2/202408:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/2/202408:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/2/202408:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/2/202408:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/2/202408:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/2/202408:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/2/202408:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/2/202408:05PRNUSSyndax Pharmaceuticals Reports Inducement Grants Under..
02/2/202408:10PRNUSSyndax Announces Participation at Two Upcoming Investor..
06/1/202408:05PRNUSSyndax Pharmaceuticals Reports Inducement Grants Under..
03/1/202408:05PRNUSSyndax Announces Presentation at 42nd Annual J.P. Morgan..
02/1/202423:00PRNUSSyndax Highlights Recent Updates and Anticipated 2024..
21/12/202300:40EDGAR2Form 8-K - Current report
20/12/202308:16PRNUSSyndax Announces Closing of Public Offering of Common Stock..
16/12/202309:29EDGAR2Form 8-K - Current report
16/12/202309:29EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
15/12/202315:07PRNUSSyndax Announces Pricing of $200 Million Public Offering of..
15/12/202308:30EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
15/12/202308:00PRNUSSyndax Announces Proposed $150 Million Public Offering of..
13/12/202308:05EDGAR2Form 8-K - Current report
13/12/202304:00PRNUSSyndax Presents Positive Data from Pivotal AUGMENT-101 Trial..
11/12/202323:30PRNUSSyndax Announces Positive Data for Revumenib in Patients..
11/12/202322:33BWIncyte und Syndax präsentieren bei ASH-Plenarsitzung weitere..
11/12/202309:00BWIncyte and Syndax Present Additional Data from Positive..
04/12/202323:00PRNUSSyndax to Host Investor Event to Discuss Axatilimab and..
02/12/202308:05PRNUSSyndax Pharmaceuticals Reports Inducement Grants Under..
22/11/202301:00PRNUSSyndax Announces Data from Pivotal AUGMENT-101 Trial of..
07/11/202323:00PRNUSSyndax Announces Participation at Stifel Healthcare..
04/11/202307:05PRNUSSyndax Pharmaceuticals Reports Inducement Grants Under..
03/11/202307:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/11/202307:05PRNUSSyndax Pharmaceuticals Reports Third Quarter 2023 Financial..
03/11/202307:03EDGAR2Form 8-K - Current report
03/11/202300:00PRNUSSyndax Announces Results from the Pivotal AGAVE-201 Trial of..
01/11/202307:26EDGAR2Form SC 13G - Statement of acquisition of beneficial..

Your Recent History

Delayed Upgrade Clock